Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of a Selective Cytopheric Device (SCD) in Patients With Acute Renal Failure

This study has been completed.
Sponsor:
Collaborators:
Harvard Clinical Research Institute
Medtox
Information provided by (Responsible Party):
CytoPherx, Inc
ClinicalTrials.gov Identifier:
NCT01072682
First received: February 17, 2010
Last updated: August 31, 2011
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)